S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis
Wentao Xu, Huina Li, Wei Zhang, Ge Bai, Chengyong Shen, Kejing Zhang
Journal:MOLECULAR CELL
IF:16.6
DOI:10.1016/j.molcel.2026.04.016
PMID:
Published:2026-05-11
research field:神经科学分子生物学细胞生物学蛋白质修饰神经退行性疾病
Abstract
TDP43 inclusion bodies are widely present in the majority of patients with familial and sporadic amyotrophic lateral sclerosis (ALS). The mechanisms regulating TDP43 solubility remain incompletely understood. Here, we report that TDP43 undergoes S-acylation primarily at the Cys244 residue by the S-acyltransferase zDHHC23. This S-acylation maintains the liquid-like properties of TDP43 by reducing the aberrant interaction with poly(ADP-ribose) polymerase 1 (PARP1) and PARylated proteins, thereby countering the pathological condensation of TDP43. S-acylation-deficient TDP43 inclusions sequester the translational machinery and inhibit cytoplasmic protein translation, ultimately resulting in neurotoxicity. Importantly, TDP43 S-acylation is decreased in the familial ALS-associated TDP43 mutants as well as in SOD1-G93A mice and C9orf72-ALS induced pluripotent stem cell (iPSC)-derived neurons, suggesting the widespread involvement of TDP43 S-acylation in ALS pathogenesis. Our findings reveal an undescribed modification of TDP43 and provide deeper insight into the regulation of TDP43 pathological condensation in ALS.
本文使用的Yeasen产品


